Cystatin C-based AKI Staging in Critically Ill Patients: Methodological Concerns and Clinical Caveats From a Nephrology Perspective

Meng Li, Zhining Mo

Open source

DOI
10.1016/j.ekir.2026.106986
Published
2026-10
Container
Kidney International Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2026.106986,
  title = {Cystatin C-based AKI Staging in Critically Ill Patients: Methodological Concerns and Clinical Caveats From a Nephrology Perspective},
  author = {Meng Li and Zhining Mo},
  year = {2026},
  journal = {Kidney International Reports},
  doi = {10.1016/j.ekir.2026.106986},
  url = {https://doi.org/10.1016/j.ekir.2026.106986}
}

RIS

TY  - JOUR
TI  - Cystatin C-based AKI Staging in Critically Ill Patients: Methodological Concerns and Clinical Caveats From a Nephrology Perspective
AU  - Meng Li
AU  - Zhining Mo
PY  - 2026
JO  - Kidney International Reports
DO  - 10.1016/j.ekir.2026.106986
UR  - https://doi.org/10.1016/j.ekir.2026.106986
ER  - 

APA

Li, M., & Mo, Z. (2026). Cystatin C-based AKI Staging in Critically Ill Patients: Methodological Concerns and Clinical Caveats From a Nephrology Perspective. Kidney International Reports. https://doi.org/10.1016/j.ekir.2026.106986

Source records